Loading clinical trials...
Loading clinical trials...
Perspective, Randomized Controlled Study Aimed at Evaluating the Effectiveness of the EmoLED Medical Device in the Healing of Digital Ulcers in Patients Affected by Scleroderma. (S.U.I.T.A.B.L.E.)
Conditions
Interventions
EmoLED treatment
current Standard of Care
Locations
1
Italy
AOU Careggi - SOD Reumatologia - Scleroderma Unit
Florence, Italy
Start Date
April 22, 2022
Primary Completion Date
March 6, 2024
Completion Date
March 6, 2024
Last Updated
June 7, 2024
NCT07550673
NCT06372613
NCT07537634
NCT06383013
NCT07541196
NCT07374471
Lead Sponsor
Emoled
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions